Keybank National Association Axonics, Inc. Transaction History

Keybank National Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$39.5 - $64.42 $148,046 - $241,446	-3,748 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$43.74 - $62.76 $4,417 - $6,338	-101 Reduced 2.62%	3,748 $235,000
Q4 2021 Feb 07, 2022	SELL	$50.01 - $73.35 $25,155 - $36,895	-503 Reduced 11.56%	3,849 $216,000
Q3 2021 Nov 08, 2021	SELL	$59.21 - $78.66 $828 - $1,101	-14 Reduced 0.32%	4,352 $283,000
Q2 2021 Aug 12, 2021	BUY	$51.39 - $66.9 $154 - $200	3 Added 0.07%	4,366 $277,000
Q1 2021 May 07, 2021	SELL	$49.14 - $59.89 $9,680 - $11,798	-197 Reduced 4.32%	4,363 $261,000
Q4 2020 Feb 09, 2021	BUY	$42.19 - $51.5 $192,386 - $234,840	4,560 New	4,560 $228,000

201

41.6M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.